InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Malley Thomas, 董事. Insider active across 5 companies, notably BeiGene, Ltd.. Aggregated, 10 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €525k. History available since 16 June 2021. The latest transaction was filed on 18 March 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Malley Thomas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
10,000 股@ US$3.124.9% 占其流量Common StockSEC:0001193125-26-116834:0
21,959 股@ US$1.86100.0% 占其流量Class A Ordinary SharesSEC:0001415889-25-021941:0
3,173 股Class A Ordinary SharesSEC:0001415889-25-015796:0
4,373 股Class A Common SharesSEC:0001415889-24-016002:0
5,000 股Class A Common SharesSEC:0001415889-23-010564:0
50,000 股@ US$11.50100.0% 占其流量Common stockSEC:0001209191-23-038797:0
标准退出：2023年9月14日 (T+90)
12,922 股0Ordinary SharesSEC:0001651308-23-000097:0
16,692 股0Ordinary SharesSEC:0001651308-22-000104:0
7,800 股0Ordinary SharesSEC:0001651308-21-000121:0
1,356 股Common StockSEC:0001179110-16-017273:0
10 条申报中的 10 条
About Malley Thomas
Malley Thomas is Administrateur and has 10 filings in total. In the sampled recent filings, they cover the period from 2016-01-05 to 2026-03-20, with transactions mainly consisting of option exercises, and a buy volume of EUR 525309 versus EUR 0 in sales. They are listed as a director of BeiGene, Ltd., Kura Oncology, Inc., Kiniksa Pharmaceuticals International, plc, Kiniksa Pharmaceuticals, Ltd., and OvaScience, Inc.
